Sentence examples for evaluate the rationale of from inspiring English sources

This study was designed to evaluate the rationale of tear-oriented conservative ascending/hemiarch replacement, comparing it against total arch replacement.

Therefore, we designed a patterns-of-failure study after complete surgery in resected pN2 disease to evaluate the rationale of the proposed PORT CTVs based on the most likely sites of nodal failure, and the institutional standard CTV delineation for PORT was developed in our hospital [ 18].

We encourage readers to evaluate the rationale for the discussion of biases within the studies as these represent a critical component – transparency – of the systematic review methodology.

But in a letter sent to Mr. Powell in June 2002, Mr. Tauzin himself wrote: "The commission must evaluate the rationale for requiring the unbundling of a network element based upon specific geographic and class-of-customer characteristics of individual markets across the nation.

Sponsors should also evaluate the rationale and the appropriateness of the recall period for a PRO instrument.

Objectives: We sought to evaluate the rationale, methodological quality, and reporting of cRCTs in critical care medicine (CCM).

Evaluate the rationale for the proposals that prior to a wider use of proton radiation therapy there must be supporting data from phase III clinical trials.

Kristjansdottir and Dizon have recently reviewed the role of HER-dimerization inhibitors, in particular evaluating the scientific rationale of pertuzumab in ovarian cancers.

This study explores the perceptions of CAM by cardiac patients using in-depth interviews to evaluate the perceived rationale, therapeutic outcomes, challenges, influences, and public health concerns.

Collectively, these observations provided us the rationale to evaluate the ability of BLyS to act as a co-stimulant for a T-dependent antibody response in vivo.

The exclusive ability of lapatinib to actively promote the extracellular release of FASN via AMPK-sensed energy depletion in metabolically demanding HER2-driven BC cell growth might provide a molecular rationale to evaluate the predictive value of circulating FASN in HER2-positive BC patients receiving lapatinib.